EU Approves TEPKINLY® for Relapsed/Refractory Follicular Lymphoma
NORTH CHICAGO, Ill.- AbbVie recently announced that the European Commission (EC) has…
AbbVie Completes Acquisition of Cerevel Therapeutics
North Chicago- August 2024- AbbVie announced that it has completed its acquisition…
AbbVie Launches Contest to Empower People Living with Migraine in their Careers
June 20204- AbbVie launched the AbbVie Migraine Career Catalyst Award, a first-of-its-kind…
AbbVie Completes Acquisition of Landos Biopharma
North Chicago- May 2024- AbbVie announced that it has completed its acquisition…
SkinMedica® Empowers Clear Skin Confidence with a New, Modern Approach to Acne
Irvine- April, 2024- Allergan Aesthetics, an AbbVie company announced the launch of…
AbbVie to Acquire Landos Biopharma
NewYork- April 2024- AbbVie and Landos Biopharma announced a definitive agreement under…
Game-Changing Cancer Treatment: AbbVie and Umoja Biopharma Partner Up
North Chicago, USA- Pharmaceutical giant AbbVie and early clinical-stage biotech company Umoja…
